U.S. flag

An official website of the United States government

NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys) AND Epilepsy, progressive myoclonic, 3, with intracellular inclusions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 13, 2012
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000030608.4

Allele description [Variation Report for NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)]

NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)

Gene:
KCTD7:potassium channel tetramerization domain containing 7 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q11.21
Genomic location:
Preferred name:
NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)
HGVS:
  • NC_000007.14:g.66638912C>T
  • NG_028110.2:g.15032C>T
  • NM_001167961.2:c.550C>T
  • NM_153033.5:c.550C>TMANE SELECT
  • NP_001161433.1:p.Arg184Cys
  • NP_694578.1:p.Arg184Cys
  • NP_694578.1:p.Arg184Cys
  • LRG_835t1:c.550C>T
  • LRG_835:g.15032C>T
  • LRG_835p1:p.Arg184Cys
  • NC_000007.13:g.66103899C>T
  • NM_153033.4:c.550C>T
  • Q96MP8:p.Arg184Cys
Protein change:
R184C; ARG184CYS
Links:
UniProtKB: Q96MP8#VAR_068779; OMIM: 611725.0002; dbSNP: rs387907246
NCBI 1000 Genomes Browser:
rs387907246
Molecular consequence:
  • NM_001167961.2:c.550C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153033.5:c.550C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Epilepsy, progressive myoclonic, 3, with intracellular inclusions
Identifiers:
MedGen: C4017260

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000053286OMIM
no assertion criteria provided
Pathogenic
(Jul 13, 2012)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.

Staropoli JF, Karaa A, Lim ET, Kirby A, Elbalalesy N, Romansky SG, Leydiker KB, Coppel SH, Barone R, Xin W, MacDonald ME, Abdenur JE, Daly MJ, Sims KB, Cotman SL.

Am J Hum Genet. 2012 Jul 13;91(1):202-8. doi: 10.1016/j.ajhg.2012.05.023. Epub 2012 Jun 28.

PubMed [citation]
PMID:
22748208
PMCID:
PMC3397260

Details of each submission

From OMIM, SCV000053286.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 Mexican sibs with infantile onset of progressive myoclonic epilepsy (EPM3; 611726) and intracellular inclusions, consistent with a diagnosis of neuronal ceroid lipofuscinosis (designated CLN14), Staropoli et al. (2012) identified a homozygous 550C-T transition in exon 4 of the KCTD7 gene, resulting in an arg184-to-cys (R184C) substitution. The mutation was found by exome sequencing and confirmed by Sanger sequencing. Each unaffected parent was heterozygous for the mutation, which was not found in over 6,000 controls. In cerebellar cells, wildtype KCTD7 showed broad, punctate cytoplasmic localization and distinct signal at the plasma membrane, whereas mutant A184C showed more diffuse cytoplasmic localization, markedly diminished signaling at the plasma membrane, and prominent cytoplasmic aggregates. These results suggested that the mutation affects the trafficking and/or solubility of KCTD7. Studies in HEK293T cells showed that the R184C mutation abrogated the interaction with cullin-3 (CUL3; 603136), which Staropoli et al. (2012) suggested may lead to an accumulation of toxic intracellular proteins.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024